GLP-1 drugs may help some women get hired
A study on the use of GLP-1 drugs shows they may be helping some women get ahead in their careers. CBS MoneyWatch reporter Megan Cerullo has more.
Wegovy
Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.
New study on stopping weight loss drugs
Popular weight loss drugs like GLP-1 injections are helping millions of people lose pounds. But a new study shows that stopping these medications can cause the weight to rapidly come back and reverse positive health effects. CBS News medical contributor Dr. Céline Gounder has more.
Novo Nordisk debuts Wegovy weight-loss pill in the U.S.
FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.
Details on FDA-approved GLP-1 pill for weight loss
The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly Lofton, director of the Medical Weight Management Program at NYU Langone, joins CBS News to discuss.
FDA approves Wegovy pill for weight loss
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
FDA approves weight loss drug in daily pill form
Regulators at the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication approved to treat obesity. Dr. Jon LaPook has more.
Measles entrenching in U.S., doctor says
A measles outbreak in South Carolina is worsening with 138 cases reported in the state. CBS News' Skyler Henry and Dr. Céline Gounder have more.
How GLP-1 drugs are shifting consumer habits
The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are spending their time and money. Washington Post retail reporter Jaclyn Peiser explains.
GLP-1 drugs and muscle loss: What to know
A recent KFF poll revealed that one in eight adults in the U.S. is currently taking a GLP-1 weight loss drug. As more people start using them, some are talking about the unexpected side effects, including muscle loss and weakness. Senior Vox correspondent Dylan Scott joins CBS News to share what patients told him.
Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic
The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy the drugs directly.
Trump announces deal to lower weight loss drug prices in some cases
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
Trump unveils deal to cut weight loss drug prices
President Trump announced a deal to drastically lower the price of weight loss drugs for some Americans. Dr. Jon LaPook has more.
Novo Nordisk CEO on Trump drug prices deal
President Trump on Thursday unveiled agreements slashing the prices of two pharmaceutical companies' weight loss drugs. Novo Nordisk CEO Mike Doustdar joins "The Takeout" to unpack the cost-cutting effort.
Costco now sells Ozempic and Wegovy at its pharmacies
A one-month supply of Ozempic and Wegovy will now cost $499 out of pocket for Costco shoppers.
Costco to sell weight loss drugs
Shoppers can now find Ozempic and Wegovy at Costco. It says it is partnering with drugmaker Novo Nordisk to offer the drugs at a steep discount for members with a prescription. CBS News reporter Andres Gutierrez has more.
Inside the weight loss drug price war
The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the price of Wegovy, a medication with the same active ingredient that's approved for weight loss. Dr. Celine Gounder has more on the emerging price competition over the drugs.
Positive results for new weight loss pill
Drugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a pill. Dr. Jon LaPook reports.
Novo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing"
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.
Generic versions of Ozempic and Wegovy banned
Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for millions. Dr. Celine Gounder joins to explain what this means for patients.
Trump won't force Medicaid to cover GLP-1s for obesity. A few states are.
Late last year, South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But access remains limited.
Patients fear losing affordable weight loss drugs
Weight loss drugs for many people may soon get a lot more expensive -- a shortage of them had actually led to lower prices. Kris Van Cleave explains how that happened and why prices could go up.
Zepbound tops Wegovy for weight loss in study comparing the drugs
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
Ozempic ingredient may reverse liver disease
There could be a new use for semaglutide, the main ingredient of weight loss and diabetes drugs Wegovy and Ozempic. Dr. Jon LaPook explains a study sponsored by the drugmaker found it could treat a common liver disease by reducing inflammation and scarring.
Can weight loss drugs help with dementia risk? Here's what studies suggest.
Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.
Tennessee prison system head to resign after failed Christa Pike execution
Live
Senior Trump administration officials met to discuss Iran war at Camp David
Medical plane missing near Nantucket with 6 on board, authorities say
Trump urges daylight saving time bill supporters to personally call Sen. Cotton
Iowa approves pricy foreign-owned steel plant project in swing district
Zach Bryan wears "Free Palestine" shirt during concert at Gillette Stadium
Jane Doe's attorney says "she was incapable of consent," alleges cover-up
More details emerge about FlyDubai co-pilot who tried to crash plane
